CTRI/2024/02/062245尚未招募2 期
A Phase II Randomised controlled trial comparing pulmonary complications in retrosternal vs posterior mediastinal gastric conduit placement in patients undergoing Esophagectomy - NI
AIIMS NEW DELHI0 个研究点目标入组 0 人开始时间: 待定最近更新:
试验速览
- 阶段
- 2 期
- 状态
- 尚未招募
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •1.Patients with resectable carcinoma esophagus planned for transthoracic esophagectomy after neoadjuvant treatment (NACT/NACTRT)
- •2.ECOG (Eastern cooperative oncology group) performance status 0 and 1
排除标准
- •1.Locally advanced esophageal cancer deemed unresectable as per MDT discussion
- •2.Metastatic/Recurrent esophageal cancer
- •3.Increased pulmonary risk (FEV1 <70 percent predicted, FVC <70 percent predicted, FEV1/FVC ratio <0.65)
- •4.Increased cardiac risk (status post myocardial infarction, grade IV NYHA)
- •5.Intrathoracic anastomosis, and reconstruction with other conduits such as colon and jejunum.
- •6.History of treatment for previous malignancy.
- •7.Pregnant or lactating women.
- •8.Patient refused for consent for the study.
研究者
相似试验
已完成
2 期
A phase II randomized controlled trial comparing perioperative mFOLFOXIRI with perioperative chemoradiotherapy for locally advanced rectal cancer.Rectal cancerJPRN-UMIN000018624Osaka Medical College Hospital34
尚未招募
2 期
A phase II Randomized controlled trial A comparison of short-course radiation and chemotherapy with or without intraperitoneal paclitaxel for locally advanced, non-metastatic signet-ring cell rectal cancersCTRI/2024/04/065785Tata Memorial Centre
招募中
2 期
A randomized controlled phase 2 trial comparing the safety and usefulness of robot-assisted esophagectomy and thoracoscopicJPRN-jRCT1040220153Takeuchi Hiroya90
进行中（未招募）
1 期
A randomized comparative phase II trial evaluating the capacity of the dualcombination doravirine/raltegravir to maintain virological success in HIV-1infected patients with an HIV-RNA plasma viremia below 50 copies/mL under acurrent antiretroviral regimen.HIV-1 INFECTIONEUCTR2019-004195-19-ITCentre de Recherche et d’Etudes sur la Pathologie Tropical et le Sida (CREPATS)150
进行中（未招募）
1 期
A randomized comparative phase II trial evaluating the capacity of the dual combination doravirine/raltegravir to maintain virological success in HIV-1 infected patients with an HIV-RNA plasma viremia below 50 copies/mL under a current antiretroviral regimeEUCTR2019-004195-19-FRCentre de Recherche et d’Etudes sur la Pathologie Tropicale et le Sida (CREPATS)150